DIAGNOSTIC METHODS OF FRAILTY SYNDROME USED IN 2018-2023: SCOPING REVIEW PUBMED

2024

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.53511/pharmkaz.2024.31.14.017
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Background: Frailty syndrome is a pathological, reversible aging process where frailty and comorbidity have a bidirectional relationship. It is characterized by having three of more of the following components: weight loss, exhaustion, slowness, low activity level, and weakness. Methods: We searched PubMed from January 1, 2018 to November 1, 2023. The dates of publication, language of publication, methodological characteristics and the key findings were analyzed separately. Results: We found 550 unfinished studies on the use of diagnostic methods for the Frailty syndrome. Only 26 suitable articles were found. 19 randomised controlled trials, 2 cohort study, 2 cross-sectional study, 1 case study,1 longitudinal study, 1 report. Conclusion: We conducted this evaluation review in order to identify clinical examples of the use of diagnostic methods of fragility syndrome in the period from 2018 to 2023. Only 26 suitable articles were found. This suggests that this topic has been little studied. There is not enough evidence. It is necessary to conduct more original research on this topic.